{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiemvuceb5j745zvejpl4fnzwa27w5qi2t7j56gl6w7a4sdvzd2bqu",
    "uri": "at://did:plc:p3227y2hdjlcc64d55t4c5y4/app.bsky.feed.post/3mk6t4m4qbfa2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifyx6fd73qwzmtf4jmigtwp473dw5ew2s4pl7blf2nttfnngjyuca"
    },
    "mimeType": "image/jpeg",
    "size": 76895
  },
  "path": "/2026/04/23/medical-marijuana-rescheduling-is-legally-puzzling-but-a-huge-win-for-patients-suppliers-and-scientists/",
  "publishedAt": "2026-04-23T18:20:51.000Z",
  "site": "https://reason.com",
  "tags": [
    "Cannabis Research",
    "Drug Legalization",
    "Drug Policy",
    "Marijuana",
    "Marijuana Business",
    "Medical Marijuana",
    "Medicine",
    "Science",
    "War on Drugs",
    "Attorney General",
    "Controlled substance",
    "DEA",
    "Department of Health and Human Services",
    "Department of Justice",
    "Donald Trump",
    "FDA",
    "Regulation",
    "Statutory Interpretation",
    "Trump Administration"
  ],
  "textContent": "Acting Attorney General Todd Blanche and President Donald Trump against a backdrop of cannabis plants",
  "title": "Medical Marijuana Rescheduling Is Legally Puzzling but a 'Huge Win' for Patients, Suppliers, and Scientists"
}